tiprankstipranks
Molecular Partners (MOLN)
NASDAQ:MOLN
US Market

Molecular Partners (MOLN) Income Statement

Compare
27 Followers

Molecular Partners Income Statement

Last quarter (Q4 2024), Molecular Partners's total revenue was CHF0.00, a decrease of -100.00% from the same quarter last year. In Q4, Molecular Partners's net income was CHF-11.23M. See Molecular Partners’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
CHF 4.97MCHF 7.04MCHF 189.56MCHF 9.33MCHF 9.34M
Gross Profit
CHF 4.97MCHF -40.81MCHF 138.81MCHF -46.39MCHF -46.73M
Operating Expenses
CHF 66.19MCHF 20.30MCHF 72.94MCHF 72.75MCHF 67.67M
Depreciation and Amortization
CHF 2.37MCHF 2.42MCHF 2.39MCHF 2.56MCHF 2.89M
EBITDA
CHF -51.65MCHF -59.53MCHF 120.85MCHF -60.85MCHF -59.59M
Operating Income
CHF -61.22MCHF -61.11MCHF 116.61MCHF -63.42MCHF -58.33M
Other Income/Expenses
CHF 7.18MCHF -876.00KCHF 1.24MCHF -365.00KCHF -4.45M
Pretax Income
CHF -54.04MCHF -61.98MCHF 117.85MCHF -63.78MCHF -62.77M
Net Income
CHF -54.04MCHF -61.98MCHF 117.85MCHF -63.78MCHF -62.76M
Per Share Metrics
Basic EPS
CHF -1.63CHF -1.89CHF 3.63CHF -2.06CHF -2.51
Diluted EPS
CHF -1.63CHF -1.89CHF 3.54CHF -2.06CHF -2.51
Weighted Average Shares Outstanding
33.19M 32.77M 32.47M 31.01M 25.00M
Weighted Average Shares Outstanding (Diluted)
33.19M 32.77M 33.27M 31.01M 25.00M
Currency in CHF

Molecular Partners Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis